Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05724823

Virtual Physical Activity Seated Exercise - Phase 2

Assessing a Telehealth Seated Exercise Program on Post-stroke Balance and Mobility: a Mixed-method Design

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will determine the acceptability of delivering seated exercises online and if seated exercises can improve balance, mobility, quality of life, and cardiometabolic health in those living with a stroke related mobility impairment. Participants will be allocated to either a 10-week seated exercise program or a delayed 2-week Boot Camp program. All seated exercises sessions and assessments will be conducted virtually.

Detailed description

The study will be a virtual 10-week multi-site, assessor-blinded, randomized controlled trial with an embedded qualitative component. The study will be conducted in real time using secure videoconferencing software (Zoom). Participants will be randomized 1:1 to a 10-week Seated Exercise group or a delayed 2-week Seated Exercise Group (Boot Camp). Seated exercise sessions will be delivered and supervised by a trained instructor. Participants will use their own computer, laptop, or tablet for the zoom sessions. No Zoom sessions will be recorded. Caregivers will be invited to attend each exercise session to provide support and assistance but are not obliged to attend. A caregiver, friend, or family member will be required for each assessment to participate in the study.

Conditions

Interventions

TypeNameDescription
OTHERVirtual Physical Activity Seated Exercises (V-PASE)The seated exercise program includes a variety of upper and lower limb strengthening, core strengthening, agility (fast arm and leg movements), and flexibility exercises. Participants will be supervised during each session thru videoconferencing by a trained instructor.

Timeline

Start date
2023-10-11
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2023-02-13
Last updated
2025-03-10

Locations

5 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT05724823. Inclusion in this directory is not an endorsement.